This website sets cookies which are used to offer a personalized experience on our website, generate statistics, and realize advertising or social network tracking. Find out more about our Privacy & Cookie policy and how to manage them on your browser. You can change your cookie settings at any time.

Out of public health concerns and given the current travel restrictions and lab closures worldwide because of COVID-19, the 27th International Symposium on Hepatitis C Virus and Related Viruses (HCV2020), scheduled to take place July 6 – 9, 2020 in Montreal, Canada has been postponed to July 6 - 9, 2021 and will now be delivered Virtually.

Speakers

Michael_Diamond.png

Michael Diamond

The Herbert S. Gasser Professor
Washington University, School of Medicine Saint Louis
USA

Dr. Diamond’s laboratory studies the molecular basis of disease of globally emerging RNA viruses, and focuses on the interface between pathogenesis and host immunity. He identified many of the key innate and adaptive immune system components that define protection against flaviviruses, and the viral genes that antagonize this response. His laboratory made a seminal discovery by identifying a novel pathogen-associated molecular pattern (lack of 2'-O methylation on the 5' viral RNA cap) and mechanism of innate immune restriction through IFIT1 proteins. His group has used genome-wide screening to identify host factors required by viruses, including novel entry receptors for multiple alphaviruses of global concern. He has led the field in studying mechanisms of pathogenesis of Zika virus infection and disease including in pregnancy, and more recently studied how the microbiome modulates immunity and infection of arthropod-transmitted viruses His group also has generated, characterized, and mapped thousands of neutralizing antibodies against Zika, West Nile, Dengue, Mayaro, and Chikungunya viruses. His work has led directly to the development of antiviral therapeutic antibodies and vaccines against both flaviviruses and alphaviruses. Most recently, his laboratory has begun efforts to study the biology and pathogenesis of SARS-CoV-2 and is pursuing strategies for developing antibody and vaccine countermeasures and novel mouse models of disease and identifying correlates of immune protection.

Dr. Diamond is an elected member of the American Society of Clinical Investigation, Association of American Physicians, American Association for the Advancement of Science, and the National Academy of Medicine. He is also a recipient of Stanley J. Korsmeyer Award of the American Society of Clinical Investigation and currently an elected Councilor for the Association of American Physicians.